BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Giamouzis G, Kalogeropoulos AP, Butler J, Karayannis G, Georgiopoulou VV, Skoularigis J, Triposkiadis F. Epidemiology and Importance of Renal Dysfunction in Heart Failure Patients. Curr Heart Fail Rep 2013;10:411-20. [DOI: 10.1007/s11897-013-0164-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Červenka L, Melenovský V, Husková Z, Sporková A, Bürgelová M, Škaroupková P, Hwang SH, Hammock BD, Imig JD, Sadowski J. Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula. Physiol Res 2015;64:857-73. [PMID: 26047375 DOI: 10.33549/physiolres.932977] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
2 Jingi AM, Nkoke C, Noubiap JJ, Teuwafeu D, Mambap AT, Nkouonlack C, Gobina R, Njume D, Dzudie A, Ashuntantang G. Prevalence, correlates and in-hospital outcomes of kidney dysfunction in hospitalized patients with heart failure in Buea-Cameroon. BMC Nephrol 2022;23:8. [PMID: 34979971 DOI: 10.1186/s12882-021-02641-2] [Reference Citation Analysis]
3 Červenka L, Melenovský V, Husková Z, Škaroupková P, Nishiyama A, Sadowski J. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula. Clin Exp Pharmacol Physiol 2015;42:795-807. [DOI: 10.1111/1440-1681.12419] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
4 Pfortmueller CA, Schefold JC. Hypertonic saline in critical illness - A systematic review. J Crit Care 2017;42:168-77. [PMID: 28746899 DOI: 10.1016/j.jcrc.2017.06.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
5 Otaki Y, Watanabe T, Konta T, Tamura H, Kato S, Nishiyama S, Takahashi H, Arimoto T, Shishido T, Watanabe M. The impact of kidney dysfunction categorized by urinary to serum creatinine ratio on clinical outcomes in patients with heart failure. Heart Vessels 2020;35:187-96. [PMID: 31332507 DOI: 10.1007/s00380-019-01472-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Kazory A, Elkayam U. Cardiorenal interactions in acute decompensated heart failure: contemporary concepts facing emerging controversies. J Card Fail. 2014;20:1004-1011. [PMID: 25230240 DOI: 10.1016/j.cardfail.2014.09.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
7 Miao J, Friedman E, Wu AH, Todd JA, Estis J, Xu X, Nolan N, Bishop JJ, Lenihan DJ. Clinical utility of single molecule counting technology for quantification of KIM-1 in patients with heart failure and chronic kidney disease. Clinical Biochemistry 2017;50:889-95. [DOI: 10.1016/j.clinbiochem.2017.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
8 Bakillah A, Tedla F, Ayoub I, John D, Norin AJ, Hussain MM, Brown C. Plasma Nitration of High-Density and Low-Density Lipoproteins in Chronic Kidney Disease Patients Receiving Kidney Transplants. Mediators Inflamm 2015;2015:352356. [PMID: 26648662 DOI: 10.1155/2015/352356] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
9 Moreira RI, Cunha PS, Rio P, da Silva MN, Branco LM, Galrinho A, Feliciano J, Soares R, Ferreira RC, Oliveira MM. Response and outcomes of cardiac resynchronization therapy in patients with renal dysfunction. J Interv Card Electrophysiol 2018;51:237-44. [PMID: 29460235 DOI: 10.1007/s10840-018-0330-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
10 Kala P, Sedláková L, Škaroupková P, Kopkan L, Vaňourková Z, Táborský M, Nishiyama A, Hwang SH, Hammock BD, Sadowski J, Melenovský V, Imig JD, Červenka L. Effect of Angiotensin-Converting Enzyme Blockade, Alone or Combined With Blockade of Soluble Epoxide Hydrolase, on the Course of Congestive Heart Failure and Occurrence of Renal Dysfunction in Ren-2 Transgenic Hypertensive Rats With Aorto-Caval Fistula. Physiol Res. [DOI: 10.33549/physiolres.933757] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
11 Kalogeropoulos AP, Siwamogsatham S, Hayek S, Li S, Deka A, Marti CN, Georgiopoulou VV, Butler J. Echocardiographic assessment of pulmonary artery systolic pressure and outcomes in ambulatory heart failure patients. J Am Heart Assoc 2014;3:e000363. [PMID: 24492947 DOI: 10.1161/JAHA.113.000363] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
12 Silva AR, Martini AG, Canto GL, Guerra ENDS, Neves FAR. Effects of dual blockade in heart failure and renal dysfunction: Systematic review and meta-analysis. J Renin Angiotensin Aldosterone Syst 2019;20:1470320319882656. [PMID: 31814505 DOI: 10.1177/1470320319882656] [Reference Citation Analysis]